Market Overview:
The global radio immunoprecipitation assay (RIPA) lysis buffer market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing demand for research and diagnostic applications, rising prevalence of target diseases, and technological advancements in the field of life sciences. Based on type, the global RIPA lysis buffer market can be segmented into solution and powder. Solution-based buffers are more popular among end users owing to their ease of use; however, powder-based buffers are gaining traction due to their cost-effectiveness. Based on application, the global RIPA lysis buffer market can be segmented into research laboratory, hospital, and others (including biotechnology & pharmaceutical companies and contract research organizations). Research laboratories accounted for a major share of the RIPA lysis buffer market in 2017 owing to increased R&D spending by pharmaceutical companies across the globe. Geographically, North America held a dominant position in 2017 followed by Europe and Asia Pacific.
 Lysis Buffer Industry Outlook.svg)
Product Definition:
The RIPA buffer is a lysis buffer that is used to break open cells and release their contents. This buffer contains detergents that help to solubilize proteins and other cellular components, as well as salts and acids that help to lyse the cells. The RIPA buffer is important for the Radio Immunoprecipitation Assay (RIPA) because it allows for the efficient extraction of proteins from cells.
Solution:
Solution is a chemical compound that dissolves in water and whose solubility can be changed by acid or alkali. The most common types of solutions are neutral (pH 7) and acidic ( pH 3-7). Solutions are used for lysis of the cell membranes to extract the intracellular contents. They also play an important role in immunoprecipitation protocols, wherein they act as adjuvants along with being vehicles for protein delivery to immune cells.
Powder:
Powder is a dry solid and is used as an ingredient in lysis of protein. It consists of detergents, chelating agents, and cross-linkers among others. Detergents are nonionic surfactants that lower the surface energy of liquid to facilitate the interaction between proteins and other compounds.
Application Insights:
Based on application, the global radio immunoprecipitation assay lysis buffer market is segmented into research laboratory, hospital and others. The research laboratory segment dominated the market in 2017 and this trend is expected to continue over the forecast period. This can be attributed to factors such as increasing government funding for cancer research coupled with an increase in R&D activities pertaining to cancer diagnostics & therapeutics. As a result, there has been an upsurge in demand for high-throughput screening of large numbers of compounds at once which requires lysis buffers that are free from inhibitors or have minimal inhibitory activity towards enzymes involved in downstream processes such as DNA/RNA fragmentation or protein degradation.
The hospital segment is anticipated to witness substantial growth over the forecast period owing to factors such as rising prevalence of chronic diseases like cardiovascular diseases (CVDs), diabetes mellitus type 2 and cancers which require regular medical checkups and treatments along with advanced healthcare facilities at hospitals across various regions globally.
Regional Analysis:
North America dominated the global radio immunoprecipitation assay lysis buffer market in 2017. This can be attributed to the presence of a large number of biotechnology and pharmaceutical companies, which are engaged in drug discovery and development processes. The U.S., as well as Canada, is one of the most lucrative regions for RIPA solution manufacturers owing to high demand from research laboratories across these countries.
In addition, Asia Pacific region is anticipated to witness significant growth during the forecast period due its developing economy.
Growth Factors:
- Increasing demand for Radio Immunoprecipitation Assay (RIPA) Lysis Buffer from biotechnology and pharmaceutical companies for drug discovery and development purposes.
- Rising prevalence of target diseases, which is expected to increase the demand for Radio Immunoprecipitation Assay (RIPA) Lysis Buffer over the forecast period.
- Growing number of research institutes and universities that are using Radio Immunoprecipitation Assay (RIPA) Lysis Buffer in their research activities.
- Technological advancements in the field of Radio Immunoprecipitation Assay (RIPA) Lysis Buffer that is resulting in better performance and efficiency of the product.
Scope Of The Report
Report Attributes
Report Details
Report Title
Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Research Report
By Type
Solution, Powder
By Application
Research Laboratory, Hospital, Others
By Companies
Yeasen Biotech Co., Ltd., AAT Bioquest, Inc., APExBIO Technology LLC, F. Hoffmann-La Roche Ltd, PeproTech, Inc., Thermo Fisher Scientific, Absin, Beijing Solarbio Science and Technology Co., Ltd., Beyotime Biotechnology, Boster Biological Technology Co.Ltd, Shanghai yuanye Bio-Technology Co., Lt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
180
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Report Segments:
The global Radio Immunoprecipitation Assay (RIPA) Lysis Buffer market is segmented on the basis of:
Types
Solution, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Laboratory, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Yeasen Biotech Co., Ltd.
- AAT Bioquest, Inc.
- APExBIO Technology LLC
- F. Hoffmann-La Roche Ltd
- PeproTech, Inc.
- Thermo Fisher Scientific
- Absin
- Beijing Solarbio Science and Technology Co., Ltd.
- Beyotime Biotechnology
- Boster Biological Technology Co.Ltd
- Shanghai yuanye Bio-Technology Co., Lt
 Lysis Buffer Market Overview.svg)
Highlights of The Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution
- Powder
- By Application:
- Research Laboratory
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Lysis Buffer Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
RIPA buffer is a lysis buffer used in immunoprecipitation assays. It is composed of protease inhibitors, phosphatase inhibitors, and a buffering agent.
Some of the major companies in the radio immunoprecipitation assay (ripa) lysis buffer market are Yeasen Biotech Co., Ltd., AAT Bioquest, Inc., APExBIO Technology LLC, F. Hoffmann-La Roche Ltd, PeproTech, Inc., Thermo Fisher Scientific, Absin, Beijing Solarbio Science and Technology Co., Ltd., Beyotime Biotechnology, Boster Biological Technology Co.Ltd, Shanghai yuanye Bio-Technology Co., Lt.
The radio immunoprecipitation assay (ripa) lysis buffer market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Size & Forecast, 2020-2028
4.5.1 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Size and Y-o-Y Growth
4.5.2 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Solution
5.2.2 Powder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Laboratory
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Solution
9.6.2 Powder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Laboratory
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Solution
10.6.2 Powder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Laboratory
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Solution
11.6.2 Powder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Laboratory
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Solution
12.6.2 Powder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Laboratory
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Solution
13.6.2 Powder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Laboratory
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market: Competitive Dashboard
14.2 Global Radio Immunoprecipitation Assay (RIPA) Lysis Buffer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Yeasen Biotech Co., Ltd.
14.3.2 AAT Bioquest, Inc.
14.3.3 APExBIO Technology LLC
14.3.4 F. Hoffmann-La Roche Ltd
14.3.5 PeproTech, Inc.
14.3.6 Thermo Fisher Scientific
14.3.7 Absin
14.3.8 Beijing Solarbio Science and Technology Co., Ltd.
14.3.9 Beyotime Biotechnology
14.3.10 Boster Biological Technology Co.Ltd
14.3.11 Shanghai yuanye Bio-Technology Co., Lt
